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Fig. 1. The matching result of 2-D gel map of proteins from PBMC of HCV
infected patients and healthy persons.
Fig. 2. Detecting F protein and PI3K by Western blot analysis. M: Protein
marker; 1, 4, 5: pcDNA3.0-HepG2; 2, 3, 6: pcDNA3.0-F-HepG2.
signiﬁcant inﬂuence on cell signal pathway. HCV-F protein can
activate PI3K protein and its signal cascade pathway. Therefore,
HCV-F protein may plays an important role in HCV pathogenesis.
OL-003 Secretion of hepatitis C virus E2 protein could
enhance neutralization antibodies induced by
DNA vaccine
Zhi-hui Chen1, Yi-min Tong2, Zhong-tian Qi *,2. 1Department of
Infectious Diseases, Changhai Hospital, Second Military Medical
University, Shanghai, China; 2Department of Microbiology,
Second Military Medical University, Shanghai, China
Objective: To explore the feasibility of induction of neutraliza-
tion antibodies against HCV infection by DNA vaccines.
Methods: Two expression plasmids of HCV envelope 2 protein
were constructed, plasmid pCI-1b746 encoding full length of E2
protein, and plasmid pCI-1b661 encoding hydrophobic carboxyl
terminal truncated E2. 293T cells were transfected with either
of both plasmids, respectively, and intracellular and secreted E2
protein were analyzed by Western blot or immunoﬂuorescence.
Then the plasmids were used to immunize BALB/c mouse in-
tramusclarly. The sera antibodies against E2 and hypervariable
region 1 (HVR1) were detected by ELISA and the neutralization
activity of the sera were assayed with HCV pseudotype particle
(HCVpp).
Results: Both plasmids could express HCV E2 protein, the ex-
pression product of pCI-1b746 could not secrete, while that of
pCI-1b661 could secrete into culture medium. The secretion of
HCV E2 protein enhanced antibody response elicited by DNA vac-
cines in mice signiﬁcantly. Sera from pCI-1b661 immunized mice
showed stronger neutralization activity than that from pCI-1b746
immunized mice. For sera from pCI-1b661 immunized mice, the
neutralization activity against HCVpp were positive correlation
with anti-HVR1 antibodies levels.
Conclusions: Secretion of E2 protein by DNA vaccine can enhance
the production of neutralization antibodies against HCVpp infec-
tion and the neutralizing activity is depended on the presence of
HVR1 antibodies.
OL-004 Suppression of liver ﬁbrosis is associated with the
decrease of transforming growth factor-β1 and
increase of matrix metalloproteinase-1
expression after interferon-α therapy in chronic
hepatitis C patients
Yun-ru Li *. Beijing Ditan Hospital, Beijing, China
Aim: To evaluated relationship of the changes of transforming
growth factor-β1 (TGF-β), matrix metalloproteinase-1 (MMP-1)
and tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) ex-
pression with liver ﬁbrosis in liver tissue after IFN-α therapy in
patients with chronic hepatitis C.
Methods: Eleven patients with chronic hepatitis C treated by
IFN-α were divided into two groups on the outcome of therapy,
including a complete responder group (CR) and a non-responder
group (NR). Liver biopsy specimens were stained with hema-
toxylin and eosin (HE) and Masson’s trichrome staining. Liver
ﬁbrosis was semiquantitated by Modiﬁed Ishak scoring system.
Results: There was a signiﬁcant reduction in Ishak ﬁbrosis score
in SVR group (P<0.05). The TGF-β1 expression was reduced and
the MMP-1 expression was elevated in SVR groups after IFN-α
therapy (P<0.05). The ratio of the density of MMP-1 to TIMP-1
expression increased in SVR group after IFN-α therapy compared
with NR group (P<0.05). The reduction of ﬁbrosis score corre-
lated signiﬁcantly with that of TGF-β1 expression in all patients
(R=0.744, P<0.01). The increase of MMP-1 expression after IFN-α
therapy signiﬁcantly correlated with the decrease of ﬁbrosis
(R=-0.925, P<0.05) and HAI (R=-0.837, P<0.05) scores in SVR
group.
Conclusion: IFN-α improves liver ﬁbrosis in hepatitis C patients
by decreasing TGF-β1 expression, as well as by increasing MMP-1
expression to degrade ﬁbrosis.
OL-005 Immunohistochemical study of hepatic oval cells
in fetal liver and chronic C hepatitis
Maria Comanescu*,1, Violeta Comanescu2. 1University Clinical
Hospital of Bucharest, Romania; 2County Clinical Hospital of
Craiova, Romania
Background: Hepatic oval cells differentiate into two types of
cells, hepatocytes and biliary cells. The aim of this study was to
identify oval cells in fetal liver and in adult liver from patients
with chronic C hepatitis.
Method: This study was performed using two study group. The
ﬁrst included 10 human fetal livers from embryos from ther-
apeutical abortions with gestational ages ranging betwwen 10
and 21 weeks. The second group included 30 liver biopsies from
patients with viral C hepatitis. The liver specimens were ﬁxed
in formaldehyde, embedded in parafﬁn and cut at 5 μm. Slides
were stained using standard (HE, VG) and immunohistochemical
stainings (CK19, CD45, alfaSMA and desmin).
Results: All cases were examined by light microscopy. Oval cells
were identiﬁed as small cells with basophilic cytoplasm and
small oval nuclei, located in periportal areas, and in association
with ﬁbrosis and inﬂammation. They were positive for CK19 and
negative for CD45. Desmin was positive in fetal hepatocytes and
negative in adult hepatocytes. Alfa SMA was positive in periportal
cells and negative in hepatocytes and biliar ducts. In chronic C
hepatitis alfa SMA was positive in isolated cells in the areas of
necrosis.
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Conclusion: Demonstrating the association between the pres-
ence of oval cells and the progression of liver diseases could
provide an useful marker for understanding the correlation be-
tween the presence of oval cells and progression of disease and
creation of future treatment.
OL-006 Efﬁcacy, tolerability and safety of personalized
low-dose IFN treatment in patients with
HCV-related liver cirrhosis and severe
complications
Xiaoling Fan*, Wenyan Zhang, Yun-ru Li, Xiaojie Wang. Beijing
Ditan Hospital, Beijing, PR China
Object: To observe the efﬁcacy, tolerability and safety of per-
sonalized low-dose IFN treatment in patients with HCV-related
liver cirrhosis and severe complications.
Method: Personalized low-dose IFN treatment was performed in
61 patients. Less than 3 million units of personalized low-dose
natural IFN-alpha was administered QOD intramuscularly or less
than 50 μg Peg-IFN alpha-2b QW intrasubcutaneously, which de-
pended on patients tolerability, and plus Ribavirin 600 mg/day.
The course of treatment was at least 24 weeks. Some patients
received more than 2 years IFN maintenance therapy.
Results: Twenty of the 62 patients showed a rapid virological
response in 4 weeks treatment (32.25%). Twenty eight of 62
patients showed a complete early virological response in 12
weeks treatment (45.16%). Thirty four of 62 patients showed HCV
RNA undetectable in 24 weeks IFN therapy (54.83%). ALT levels
normalized (about 40 IU/L) at the end of 24 weeks therapy. 11
of 25 patients had a sustained virological response who were
given more than 2 years Maintenance Therapy (44%). Deﬁnitive
discontinuation of therapy was necessary in 7 patients (11.29 %)
because of side effects.
Conclusion: Personalized low-dose IFN and ribavirin combination
therapy was useful and safe in some patients with HCV-related
liver cirrhosis and severe complications for whom standard-dose
interferon and ribavirin combination therapy was difﬁcult.
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OL-007 Carbapenems resistance in Gram-negative bacilli
isolates in an intensive care unit
Eleni Antoniadou*,1, Spyridoula Vasiliagkou1, Nikolaos
Voloudakis 2, Savvato Tsingene3, Asimoula Koteli 3. 1Intensive
Care Unit, "G. Gennimatas" General Hospital of Thessaloniki;
2Medical School, University of Crete, Heraklion; 3Microbiology
Laboratory, “G. Gennimatas” General Hospital of Thessaloniki
Objective: to determine resistance of Ps. aeruginosa, A. bau-
mannii and K. pneumonniae as prevalent nosocomial agents to
commonly used antibiotics including imipenem, meropenem and
ertapenem.
Methods: Identiﬁcation of microorganisms and susceptibility test
was performed with the Vitek 2 (BioMerieux®, France) and the
susceptibility disc diffusion method according to CLSI directions.
For Klebsiella spp. extended-spectrum Beta-lactamases (ESBLs)
production was conﬁrmed by double-disc test. To screen for
metallo-b-lactamase production (MBL), a synergy test using an
imipenem and EDTA-containing discs was employed. Quality con-
trol was ensured by keeping weekly records of disk diffusion
Ps. aeruginosa (ATCC 27853). MIC values for carbapenems were
determined by the E-test (AB Biodisk, Solona, Sweden) as recom-
mended by manufacture. K. pneumoniae ATCC 70603 was used as
a positive ESBLs strain.
Results: Information was available on antibiotic suceptibility
of 1044 gram-negative bacteria, of which the most common
were A. baumanii 414, Ps. aeruginosa 328, K. pneumoniae 169.
No duplicate isolates from the same patients were included.
All microorganisms were isolated from tracheal tube aspirates,
urine, wound, blood and other sterile body ﬂuids. The resis-
tance rates (%) of A. baumanii, Ps. aeruginosa, and K. pneu-
moniae were: imipenem 76/61/67, meropenem 68/52/65, er-
tapenem 77/65/68, amikacin 88/48/40, piperacillin/tazobactam
82/35/67, ceftazidime 100/68/65, ciproﬂoxacin 92/64/15,
aztreonam 100/84/72. Of 169 isolates of K. pneumoniae 92
(54,43%) were ESBls.
Conclusions: The most isolates of A. baumannii were multi-drug
resistant. The majority of isolates were resistant to 5 or more
antibiotics tested and some strains were deﬁned by resistance
to all antimicrobial agents except colistin. The resistance to
carbapenems rose dramatically.
OL-008 Molecular characterization of extended-spectrum
β-lactamases and AmpC enzymes in
Enterobacteriaceae in Beijing, China
Lingxiang Zhu*,1,2, Di Jiang1,2, Zhiwei Zhang1,2, Can Wang1,2,
Jing Cheng1,2. 1National Engineering Research Center for
Beijing Biochip Technology; 2CapitalBio Corporation, PR China
Objectives: A study was conducted to evaluate the molecu-
lar characterization of extended-spectrum β-lactamases (ESBLs)
and plasmid-mediated AmpC enzymes in Enterobacteriaceae in
Beijing, China.
Methods: Production of ESBLs and plasmid-mediated AmpC
among 240 non-duplicate Enterobacteriaceae isolates was
screened by the phenotypic methods and the molecular methods.
The epidemiological relationship of the isolates was studied by
random ampliﬁed polymorphic DNA (RAPD) analysis.
Results: CTX-M type ESBLs were the most prevalent ESBLs. Three
E. coli isolates simultaneously harbored blaCTX-M-3 and blaCTX-M-9
genes. SHV-12 was the most prevalent SHV-type ESBL. SHV-2a,
SHV-2 and SHV-5 ESBLs, and SHV-27 and SHV-44 non-ESBLs were
detected. Two Klebsiella pneumoniae isolates expressed a novel
ESBL, SHV-43a, which had one substitution (Leu35Gln) compared
with SHV-43. DHA-1 was the most prevalent plasmid-mediated
AmpC enzyme, found mainly in K. pneumoniae (n=11). We also
identiﬁed the plasmid-mediated CMY-2 enzyme in two E. coli iso-
lates. RAPD analysis revealed that 53 CTX-M-13- and 7 CTX-M-3-
producing E. cloacae isolates recovered from a single hospital
exhibited a high similarity of RAPD patterns, indicating clone-
related spread.
Conclusions: This survey indicates the high frequencies of CTX-
M-9/3 ESBLs and plasmid-mediated DHA-1 in China, reports the
ﬁrst emergence of DHA-1-producing E. cloacae and interhospital
epidemic CTX-M-13/3-producing E. cloacae.
OL-009 Virulence factors determination and molecular
characterisation of Malaysian Vibrio cholerae
Cindy Shuan Ju Teh*, Kwai Lin Thong. Institute of Biological
Sciences, Faculty of Science, University of Malaya, Kuala
Lumpur, Malaysia
Objective: To determine the virulence proﬁles of Malaysian Vib-
rio cholerae and to investigate the relatedness of the strains
using molecular typing methods.
Methods: 43 V. cholerae were isolated from clinical and environ-
mental sources. Strains isolated were serogrouped and PCR were
carried out for determination of the virulence genes harbored in
each strain. The strains were further characterized using molec-
ular subtyping methods such as RAPD, ERIC, REP-PCR and PFGE
ﬁngerprinting to investigate the relatedness among the strains.
Results: Twenty-three O1, one O139 and 19 non-O1/nonO139
strains were isolated. All but one O1 strains harbored virulence
genes such as ctxA, zot, rtxA, rstR, toxT, toxR, tcpA, tcpI, and
